Ze-Bo Jiang

3PUBLICATIONS
0CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 09, 2025
Plumbagin Triggers STING Pathway Activation to Suppress Non-Small Cell Lung Cancer Progression.

Li-Ping Kang, Ning-Ning Li, Pei-Sheng Chen

|Jul 02, 2025
Brazilin Inhibits the Proliferation of Non-Small Cell Lung Cancer by Regulating the STING/TBK1/IRF3 Pathway.

Li-Ping Kang, Cong Xu, Pan Xu

|Feb 24, 2025
Rutecarpine Suppresses Non-Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells.

Ze-Bo Jiang, Qing-Hua He, Li-Ping Kang

Pageof 1

Frequent Collaborators